Skip to main content

Table 1 Patient characteristics

From: Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy

 

Neoadjuvant ( n= 80)

Adjuvant ( n= 90)

P

Age (years)

60 (21–74)

59 (29–82)

0.762

Sex

  

0.982

  Male

63 (78.8%)

71 (78.9%)

 

  Female

17 (21.2%)

19 (21.1%)

 

BMI (kg/m2)

23.8

23.6

0.709

  > 25

26 (32.5%)

29 (32.2%)

 

Tumor location

  

0.135

  GEJ

32 (40.0%)

21 (23.3%)

 

  Body

15 (18.8%)

22 (24.5%)

 

  Distal

32 (40.0%)

45 (50.0%)

 

  Total

1 (1.2%)

2 (2.2%)

 

Clinical TNM stage

  

0.172

  II

4

10

 

  III

76

80

 
  1. BMI body mass index, GEJ gastroesophageal junction.